Hepatology Elsewhere
Free Access
NAFLD and NASH: Important diseases before and after liver transplantation
Andy S. Yu M.D.,
Emmet B. Keeffe M.D.,
Andy S. Yu M.D.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA
Search for more papers by this authorEmmet B. Keeffe M.D.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA
Search for more papers by this authorAndy S. Yu M.D.,
Emmet B. Keeffe M.D.,
Andy S. Yu M.D.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA
Search for more papers by this authorEmmet B. Keeffe M.D.
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA
Search for more papers by this authorNo abstract is available for this article.
References
- 1 Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434–438.MEDLINE
- 2 Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413–1419.MEDLINE
- 3 Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137–145.MEDLINE
- 4 Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106–1110.MEDLINE
- 5
Clark JM,
Brancati FL,
Diehl AE.
Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the U.S. population [Abstract].
Gastroenterology
2001;
120: A–65.
10.1016/S0016-5085(01)80321-8 Google Scholar
- 6 Pinol V, Bessa X, Bruguera M, Rodes J. Steatosis and nonalcoholic steatohepatitis. A comparative analysis. Gastroenterol Hepatol 2000; 23: 57–61.MEDLINE
- 7 Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an evolving diagnosis. Can J Gastroenterol 2000; 14: 321–326.MEDLINE
- 8 Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117–1123.MEDLINE
- 9 Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91–100.MEDLINE
- 10 Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664–669.MEDLINE
- 11 Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32: 689–692.MEDLINE
- 12 Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001; 7: 608–614.MEDLINE
- 13 Charlton MR, Kondo M, Roberts SK, Steers JL, Krom RA, Wiesner RH. Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg 1997; 3: 359–364.MEDLINE
- 14 Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26: 98–106.MEDLINE
- 15 Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000; 136: 734–738.MEDLINE
- 16 Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996; 23: 1464–1467.MEDLINE
